Literature DB >> 28499240

Establishment of a rat model of chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) induced by immunization with a novel peptide T2.

Awais Ullah Ihsan1, Farhan Ullah Khan2, Waqas Nawaz3, Muhammad Zahid Khan4, Mengqi Yang5, Xiaohui Zhou6.   

Abstract

BACKGROUND: The exact etiological mechanism of Chronic Prostatitis/chronic pelvic pain syndrome (CP/CPPS) is still unclear however autoimmunity is the most valid theory. We developed a rat model of Chronic Prostatitis/chronic pelvic pain syndrome by using a novel peptide (T2) isolated from TRPM8. This model might be beneficial in elucidating mechanisms involved in the pathogenesis of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS).
METHODS: 40 male Sprague-Dawley rats with an average weight of 180-220g were equally distributed into five groups. The normal control group was injected with normal saline (.9% NACL), the CFA group with CFA, AL(OH)3 group was given AL(OH)3 injection, T2 group using a novel peptide T2 and T2+AL(OH)3+CFA group was injected with T2+AL(OH)3+CFA. Dosing to all rat groups were injected subcutaneously. Hematoxylin and eosin staining and Immunohistochemistry were used to investigate inflammatory cell infiltration and IL-1β in the prostate tissue respectively. ELISA technique was used to measure the serum level of CRP and TNF-α. T-test was used to analyze the results.
RESULTS: Maximum infiltration of inflammatory cells and the highest level of IL-1β in the prostate tissue was observed in T2+AL(OH)3+CFA group as revealed by histopathology and Immunohistochemistry, respectively. Furthermore, T2+AL(OH)3+CFA group attained the peak value of serum TNF-α and CRP as determined by ELISA technique.
CONCLUSION: Our results demonstrated that T2 in combination with AL(OH)3 and CFA induced severe Prostatitis in rats. We believe that our present model will be highly beneficial for investigation of the pathophysiology of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Adjuvants; Autoimmunity; Chronic prostatitis; Cytokines; Experimental autoimmune prostatitis (EAP); TRPM8

Mesh:

Substances:

Year:  2017        PMID: 28499240     DOI: 10.1016/j.biopha.2017.05.004

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Novel Treatment of Experimental Autoimmune Prostatitis by Nanoparticle-Conjugated Autoantigen Peptide T2.

Authors:  Yijie Cheng; Yanfang Cao; Awais Ullah Ihsan; Farhan Ullah Khan; Xue Li; Dianyou Xie; Xingxing Cui; Wenlu Wang; Ziwei Liu; Cunyu Li; Khalil Ali Ahmad; Kiganda Raymond Sembatya; Reyaj Mikrani; Xiaohui Zhou
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  Rapamycin Alleviates Hormone Imbalance-Induced Chronic Nonbacterial Inflammation in Rat Prostate Through Activating Autophagy via the mTOR/ULK1/ATG13 Signaling Pathway.

Authors:  Yang Su; Jingxiao Lu; Xianguo Chen; Chaozhao Liang; Pengcheng Luo; Cong Qin; Jie Zhang
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

3.  An Immunogenic Peptide, T2 Induces Interstitial Cystitis/Painful Bladder Syndrome: an Autoimmune Mouse Model for Interstitial Cystitis/Painful Bladder Syndrome.

Authors:  Li Zhang; Awais Ullah Ihsan; Yanfang Cao; Farhan Ullah Khan; Yijie Cheng; Lei Han; Xiaohui Zhou
Journal:  Inflammation       Date:  2017-12       Impact factor: 4.092

4.  Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis.

Authors:  Dongxu Lin; Mengyang Zhang; Changcheng Luo; Pengyu Wei; Kai Cui; Zhong Chen
Journal:  J Immunol Res       Date:  2022-06-17       Impact factor: 4.493

Review 5.  Experimental autoimmune prostatitis: different antigens induction and antigen-specific therapy.

Authors:  Yuqian Liu; Junaid Wazir; Meng Tang; Rahat Ullah; Yueting Chen; Tingting Chen; Xiaohui Zhou
Journal:  Int Urol Nephrol       Date:  2020-11-16       Impact factor: 2.370

6.  Pain in chronic prostatitis and the role of ion channels: a brief overview.

Authors:  Asha Caroline Cyril; Reem Kais Jan; Rajan Radhakrishnan
Journal:  Br J Pain       Date:  2021-05-19

7.  AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia.

Authors:  Waqas Nawaz; Bilian Huang; Shijie Xu; Yanlei Li; Linjing Zhu; Hu Yiqiao; Zhiwei Wu; Xilin Wu
Journal:  Blood Cancer J       Date:  2021-06-23       Impact factor: 11.037

8.  Influence of Experimental Autoimmune Prostatitis on Sexual Function and the Anti-inflammatory Efficacy of Celecoxib in a Rat Model.

Authors:  Yadong Zhang; Xiangping Li; Kuikui Zhou; Mingkuan Zhou; Kai Xia; Yunlong Xu; Xiangzhou Sun; Yingjie Zhu; Chunyan Cui; Chunhua Deng
Journal:  Front Immunol       Date:  2020-09-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.